|Day Low/High||27.71 / 27.89|
|52 Wk Low/High||19.94 / 28.53|
Powerful multi-omics data management solution and highly curated 'omics' data sets complement QIAGEN's industry-leading interpretation solutions
Launch of new QIAact gene panels and customized panels service complemented by performance upgrades that further differentiate first Sample to Insight NGS sequencing solution
U.S. submission builds on 2016 launch of fourth-generation test in more than 60 countries and already used in more than 600,000 people to date
New guidelines recommend broader use of modern blood TB tests like QuantiFERON-TB Gold over the 100-year-old tuberculin skin test
New middleware co-developed with Genohm ensures full chain of custody from Sample to Insight and integrates with most LIMS systems
New improved chemistry for first Sample to Insight next-generation sequencing solution to be made available to first customers in December 2016
Adjustment to capital structure through reduction in number of shares outstanding and direct capital repayment to shareholders expected to be completed in January 2017
Compact, versatile and yet very affordable instrument provides unique front-end in workflows for molecular analysis of individual cells
Quest and IBM are rolling out a genomic sequencing service powered by Big Blue's Watson supercomputer.
All-in-One library prep kit, plus collection, stabilization and bioinformatics solutions enable NIPT and cancer research
Partnering with Hamilton Robotics to deliver automated workflows for DNA fingerprinting
Proposal would adjust capital structure through 4% reduction in number of shares outstanding and direct capital repayment to shareholders
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AEUA, BPMC, CAA, CAT, COMM, DAIO, DKS, EFII, HDS, HOG, ISTR, KEM, MSCC, MT, NWHM, QGEN, QLYS, TPRE Downgrades: COHU, DMD, EMN, GRC, SFS, SYNA, WWE Initiations: None Read on to get TheStreet Quant Ratings' detailed report:
TheStreet highlights 3 stocks pushing the diversified services industry higher today.
Qiagen (QGEN) stock is jumping on Friday morning after the company posted earnings and revenue that topped analysts’ projections for the 2016 second quarter.
Trade-Ideas LLC identified Qiagen (QGEN) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate
QIAseq Targeted NGS panels deliver highly sensitive, unbiased and accurate NGS insights
These five technical setups are showing solid upside potential right now.
Transaction will enhance leadership position in RNA solutions from Sample to Insight
Ever hear of space congestion, Bots or liquid biopsy? The phrases are part of a group of 21 investment buzzwords identified by Goldman Sachs in its annual buzzword report.